Yonglun Wang

Yonglun Wang

Auto-generated profile, based on publicly available information

Yonglun Wang

Institute of Molecular Medicine, College of Future Technology

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2022 in Journal of Superconductivity and Novel Magnetism
Verified
Journal Article
Closed access
PDF file
PLPengwei Li
Pengwei Li
Jie LiJie Li
Jie Li
WZWenhao Zhang
Wenhao Zhang
YWYonglun Wang
Yonglun Wang
KYKai Yao
Kai Yao

22 March 2022 in Cells
Verified
Journal Article
Open access
PDF file
YWYuhao Wang
Yuhao Wang
YWYonglun Wang
Yonglun Wang
FLFang Li
Fang Li
JZJie Zou
Jie Zou
XLXiaoqian Li
Xiaoqian Li
YZYuan-Yuan Zhang
Yuan-Yuan Zhang
Non-alcoholic fatty liver disease (NAFLD) held a high global prevalence in recent decades. Hepatic lipid deposition is the major characteristic of NAFLD. We aim to explore the mechanisms of psoralen on lipid deposition in NAFLD. The effects of psoralen on insulin resistance, lipid deposition, the expression and membrane translocation of glucose transporter type 4 (GLUT4), autophagy, and lipogenesis enzymes were determined on sodium oleate-induced L02 cells. Chloroquine and 3-MA were employed. The AMP-activated protein kinase alpha (AMPKα) was knocked down by siRNA. Psoralen alleviated insulin resistance in sodium oleate-induced L02 hepatocytes by upregulating the expression and membrane translocation of GLUT4. Psoralen inhibited lipid accumulation by decreasing the expression of key lipogenesis enzymes. Psoralen promotes autophagy and the autophagic flux to enhance lipolysis. Psoralen promoted the fusion of the autophagosome with the lysosome. Both chloroquine and 3-MA blocked the effects of psoralen on autophagy and lipid accumulation. The AMPKα deficiency attenuated the effects of psoralen on autophagy and lipid accumulation. Our study demonstrated that as an antioxidant, psoralen attenuates NAFLD by alleviating insulin resistance and promoting autophagy via AMPK, suggesting psoralen to be a promising candidate for NAFLD.

11 September 2021 in Physicochemical Problems of Mineral Processing
Verified
Journal Article
Open access
YWYonglun Wang
Yonglun Wang
JLJie Li
Jie Li
WZWen-Hao Zhang
Wen-Hao Zhang
PLPengwei Li
Pengwei Li
JGjing guo
jing guo
KYKai Yao
Kai Yao
Citric acid is a small-molecule organic acid, which can be used as an inhibitor for the flotation of Mg 2+ activated quartz. Methods such as flotation experiments, zeta potential, FTIR qualitative and quantitative calculations, and solution chemistry calculations were used in this study to...

10 December 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
HFHuan Fang
Huan Fang
YWYonglun Wang
Yonglun Wang
LLLu Liu
Lu Liu
KCKunlun Cheng
Kunlun Cheng
PLPei Li
Pei Li
XCXiaowei Chen
Xiaowei Chen
Host-based antivirals could offer broad-spectrum therapeutics and prophylactics against the constantly-mutating viruses including the currently-ravaging coronavirus, yet must target cellular vulnerabilities of viruses without grossly endangering the host. Here we show that the master lipid regulator SREBP1 couples the phospholipid scramblase TMEM41B to constitute a host “metabolism-to-manufacture” cascade that maximizes membrane supplies to support coronaviral genome replication, harboring biosynthetic enzymes including Lipin1 as druggable viral-specific-essential (VSE) host genes. Moreover, pharmacological inhibition of Lipin1, by a moonlight function of the widely-prescribed beta-blocker Propranolol, metabolically uncouples the SREBP1-TMEM41B cascade and consequently exhibits broad-spectrum antiviral effects against coronaviruses, Zika virus, and Dengue virus. The data implicate a metabolism-based antiviral strategy that is well tolerated by the host, and a potential broad-spectrum medication against current and future coronavirus diseases.

16 December 2025 in bioRxiv
Verified
Preprint
Open access
YWYonglun Wang
Yonglun Wang
RWRenqian Wang
Renqian Wang
YYYuanhang Yao
Yuanhang Yao
RHRongxian Hou
Rongxian Hou
LYLu Yan
Lu Yan
XCXiaowei Chen
Xiaowei Chen
The TMEM41B scramblase and its regulatory partner CLCC1 initiate lipid flux by equilibrating newly-synthesized phospholipids across the endoplasmic reticulum (ER) bilayer, a fundamental process required for diverse events ranging from membrane biogenesis to bulk lipid supply. Loss of CLCC1/TMEM41B causes ER bilayer imbalance, inducing giant ER-enclosed lipid droplets (geLDs) and driving rapid progression into severe MASH. Here we identify CLCC1 as the long-missing client of the lumenal Torsin ATPases, which selectively engage oligomerized CLCC1 at sites of ER bilayer imbalance. Hepatic TorsinA inactivation triggers geLD formation amid disrupted lipoprotein biogenesis and severe MASH, closely phenocopying CLCC1/TMEM41B deficiency. Mechanistically, Torsins act as foldases that drive CLCC1 oligomerization for its recruitment to imbalanced bilayers. Remarkably, ectopic CLCC1 expression reverses cellular and systemic lipid disorders arising from hepatic TorsinA deficiency. Hence, Torsin ATPases emerge as fundamental regulators that organizes CLCC1 and the downstream TMEM41B scramblase to govern lipid partitioning and membrane homeostasis.